FIFARMA is engaging with governments and regulatory bodies as well as with other actors involved in the development, manufacturing, registration, distribution and use of medicines to inform and educate about pharmacovigilance – formal drug safety surveillance, monitoring and reporting – as well as other relevant topics impacting quality, safety and efficacy of medicines in Latin America.
Quality & Safety
FIFARMA supports ongoing programs and initiatives to monitor the quality of medicines and patient safety in Latin America, among them:
Good Regulatory Practices
FIFARMA supports the adoption of Good Regulatory Practices as a tool to strengthen health systems in Latin America. Learn about the 4 key areas in the FIFARMA paper on Good Regulatory Practices:
Vigilantia is a Latin American-focused educational initiative led by FIFARMA and its members with a mission to bring all health stakeholders together to improve the pharmacovigilance systems in the region. Learn more about the Vigilantia initiative in the video below. Also, click here to read an article about the initiative published in the Journal Pharmaceuticals, Policy and Law.
In order to protect the life of the most vulnerable people in Latin America, the pharmaceutical industry is working on implementing a long-term plan to fight against the illicit market of medicines.
Fight the Fakes is an international campaign endorsed by FIFARMA that aims to raise awareness about the dangers of fake medicines. It seeks to build a global movement of organizations and individuals who will shine a light on the negative impact that fake medicines have on people around the globe and to reduce the negative consequences on individuals worldwide. For more information, please visit www.ﬁghtthefakes.org
You can learn more about FIFARMA’s efforts to promote quality and safety by reading the Vigilantia and Fight the Fakes reports and educational materials.
Subscribe to our newsletter and receive relevant news about our industry and region.